DAB.bio

DAB.bio develops and deploys cutting-edge fermentation technology. Our unique and patented FAST platform (Fermentation Accelerated by Separation Technology) enables continuous fermentation with cost reductions of 20-50% or more and is one of the most significant fermentation innovations of the past decade. The global focus on synthetic biology has delivered breakthrough routes to replace fossil-based chemicals with sustainable bio-based alternatives. High manufacturing costs currently hamper the large-scale manufacturing of many of these alternatives. FAST addresses this issue head-on. It is the largest contributor to lowering manufacturing costs and facilitating large-scale deployment of bio-based chemicals. DAB.bio promises a significant impact

Biomanufacturing,process development,and extractive fermentation

Dab.bio operates in the Biotechnology research industry.

Dab.bio's revenue is 11m - 100m

Dab.bio has 11 - 50 employees.